Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2024
Nanoliposomal Irinotecan With Fluorouracil and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Cholangiocarcinoma: A Phase II Study of the AIO Hepatobiliary-YMO Cancer Groups (NIFE-AIO-YMO HEP-0315)
Thomas J Ettrich, Dominik P Modest, Marianne Sinn, et al.
Cancer Research
|
August 10, 2017
ATM Deficiency Generating Genomic Instability Sensitizes Pancreatic Ductal Adenocarcinoma Cells to Therapy-Induced DNA Damage
Lukas Perkhofer, Anna Schmitt, Maria Carolina Romero Carrasco, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 26, 2025
Ivosidenib for IDH1-Mutant Intrahepatic Cholangiocarcinoma: Insights From a Multicenter Real-World Study
Monica Niger, Margherita Rimini, Florian Castet, et al.
Gut
|
September 17, 2016
Human pluripotent stem cell-derived acinar/ductal organoids generate human pancreas upon orthotopic transplantation and allow disease modelling
Meike Hohwieler, Anett Illing, Patrick C Hermann, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
July 26, 2021
Functional Genomic Screening During Somatic Cell Reprogramming Identifies DKK3 as a Roadblock of Organ Regeneration
Frank Arnold, Pallavi U Mahaddalkar, Johann M Kraus, et al.
Gut
|
September 3, 2020
Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer
Johann Gout, Lukas Perkhofer, Mareen Morawe, et al.
Cell Stem Cell
|
April 29, 2021
Modeling plasticity and dysplasia of pancreatic ductal organoids derived from human pluripotent stem cells
Markus Breunig, Jessica Merkle, Martin Wagner, et al.
Therapeutic Advances in Medical Oncology
|
February 24, 2026
Sequential or upfront triple combination with durvalumab, tremelimumab, and bevacizumab for patients with unresectable hepatocellular carcinoma: the MONTBLANC trial protocol (AIO-HEP-0325/ass)
Najib Ben Khaled, Ursula Ehmer, Ilja Kubisch, et al.
Plos One
|
November 25, 2025
GerPaCyst - The trial protocol of the prospective, multicenter, interdisciplinary German Pancreas Club Cyst Registry
Kim Christin Honselmann, Jonathan Marschner, Anna Staufenbiel, et al.
Cancer Research
|
May 11, 2026
ATM Deficiency Induces TGF-β-Mediated Stromal Programming in Pancreatic Cancer
Elodie Roger, Hannah M Mummey, Eleni Zimmer, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2024
Nanoliposomal Irinotecan With Fluorouracil and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Cholangiocarcinoma: A Phase II Study of the AIO Hepatobiliary-YMO Cancer Groups (NIFE-AIO-YMO HEP-0315)
Thomas J Ettrich, Dominik P Modest, Marianne Sinn, et al.
Cancer Research
|
August 10, 2017
ATM Deficiency Generating Genomic Instability Sensitizes Pancreatic Ductal Adenocarcinoma Cells to Therapy-Induced DNA Damage
Lukas Perkhofer, Anna Schmitt, Maria Carolina Romero Carrasco, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 26, 2025
Ivosidenib for IDH1-Mutant Intrahepatic Cholangiocarcinoma: Insights From a Multicenter Real-World Study
Monica Niger, Margherita Rimini, Florian Castet, et al.
Gut
|
September 17, 2016
Human pluripotent stem cell-derived acinar/ductal organoids generate human pancreas upon orthotopic transplantation and allow disease modelling
Meike Hohwieler, Anett Illing, Patrick C Hermann, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
July 26, 2021
Functional Genomic Screening During Somatic Cell Reprogramming Identifies DKK3 as a Roadblock of Organ Regeneration
Frank Arnold, Pallavi U Mahaddalkar, Johann M Kraus, et al.
Gut
|
September 3, 2020
Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer
Johann Gout, Lukas Perkhofer, Mareen Morawe, et al.
Cell Stem Cell
|
April 29, 2021
Modeling plasticity and dysplasia of pancreatic ductal organoids derived from human pluripotent stem cells
Markus Breunig, Jessica Merkle, Martin Wagner, et al.
Therapeutic Advances in Medical Oncology
|
February 24, 2026
Sequential or upfront triple combination with durvalumab, tremelimumab, and bevacizumab for patients with unresectable hepatocellular carcinoma: the MONTBLANC trial protocol (AIO-HEP-0325/ass)
Najib Ben Khaled, Ursula Ehmer, Ilja Kubisch, et al.
Plos One
|
November 25, 2025
GerPaCyst - The trial protocol of the prospective, multicenter, interdisciplinary German Pancreas Club Cyst Registry
Kim Christin Honselmann, Jonathan Marschner, Anna Staufenbiel, et al.
Cancer Research
|
May 11, 2026
ATM Deficiency Induces TGF-β-Mediated Stromal Programming in Pancreatic Cancer
Elodie Roger, Hannah M Mummey, Eleni Zimmer, et al.
Page
of 6